Clinical Trial Update: Alzheimer's Disease Neuroimaging Initiative 3

View source ↗

Summary

This document provides an update on the Alzheimer's Disease Neuroimaging Initiative 3 (ADNI-3) trial, involving participants with mild cognitive impairment and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: University of Southern California | Conditions: Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD) | Status: COMPLETED